MyCancerDB
Platform enables improved access to personalized cancer treatment
Private Fundraise
This company may be interested in raising funds from accredited investors. You must Request Access to see more information about this company.
Request Access 9
Market Opportunity
Fast Facts
MyCancerDB offers a cloud-native platform that helps individual cancer patients to know more, and to do more, about treating their illness. Our technology also supports institutions serving cancer patients in running therapeutic and diagnostic analyses at lower cost and at scale.
Problems
Cloud-Based Platform Provides Solutions
How It Works
Benefits of MyCancerDB
About the Founding of MyCancerDB
Our Story
Our company is owned and controlled by cancer patients, including our late founder Stephen Aldrich. Stephen was a Stage 4 adenocarcinoma of the esophagus patient who was able to use his full genomic sequence data to make optimal treatment decisions regarding his cancer.
He obtained access to personalized immunotherapy options – including a personalized neoantigen vaccine, which led to his surviving and thriving for three full years beyond expectations. Our job is to enable patients to use their data as Stephen used his — to make optimal treatment decisions and directly access advanced therapy options.
Founding Members
Founding Members are all cancer patients, as well as initial customers and investors in MyCancerDB.
Our service offering is being designed around their needs and with their input, and they act as an informal advisory board for the company.
Operating Team
